Stephan Schwers

Title: Innovations by Stephan Schwers

Introduction

Stephan Schwers is a notable inventor based in Köln, Germany. He has made significant contributions to the field of biomarker development, particularly in the context of therapeutic treatments. His innovative approach focuses on utilizing patient data to enhance the prognosis of treatment outcomes.

Latest Patents

One of Schwers' key patents is titled "Method for identifying predictive biomarkers from patient data." This invention relates to a method for developing a biomarker that predicts the results of therapeutic treatments based on data obtained from clinical studies. The method involves categorizing data that remains unchanged by therapy into diagnostic and genomic parameters. The marker is defined by a combination of these parameters, with a unique aspect of the invention being the specification of the maximum number of parameters for defining the marker. This approach allows for a systematic search for defining parameters through the sequential combination of clinical and genomic parameters.

Career Highlights

Throughout his career, Stephan Schwers has worked with prominent companies in the healthcare sector. Notably, he has been associated with Bayer Technology Services GmbH and Siemens Healthcare Diagnostics GmbH. His work in these organizations has contributed to advancements in medical diagnostics and treatment methodologies.

Collaborations

Schwers has collaborated with esteemed colleagues such as Andreas Schuppert and Rolf Burghaus. These partnerships have fostered innovation and have been instrumental in the development of his patented methods.

Conclusion

Stephan Schwers is a distinguished inventor whose work in biomarker development has the potential to significantly impact therapeutic treatments. His innovative methods and collaborations highlight his commitment to advancing medical science.